Advanced MRI coil technology will drive new high resolution
applications in small animal neuroimaging
MILANO, Italy--(BUSINESS WIRE)--
At the joint ISMRM-ESMRMB 2014 meeting, Bruker today announced a new Phased
Array MRI CryoProbe™ for in
vivo neuroimaging that delivers unparalleled access to rat brain
microstructure and biochemistry, previously unresolvable in in vivo
imaging of the rat. The sensitivity increase by up to a factor of 2.4
allows researchers to reduce imaging times by a factor of 5, or to
increase spatial resolution.
4 Channel Phased Array MRI CryoProbe™ for rat brain (Photo: Business Wire)
The 400 MHz Phased Array MRI CryoProbe is
based on cryogenically-cooled, 4 channel array, RF coil technology that
provides a combination of high sensitivity imaging and parallel
acquisition capabilities for maximum imaging speed and highest spatial
resolution in 9.4 Tesla BioSpec®
systems. This cutting-edge technology provides unrivaled delineation of
key information directly relevant to the early diagnosis of diseases,
based on the in vivo detection of microscopic anatomical and
functional abnormalities in small animals.
Benefiting from automatic selection, the probe integrates seamlessly
with Bruker’s ParaVision®
6 software, opening up a vast world of imaging protocols and
experimental capabilities to the preclinical imaging researcher. Thanks
to hardware recognition, and automatic tuning and matching for optimum
performance and productivity, the Phased Array MRI
CryoProbe is suited to routine imaging environments. The
corresponding CryoPlatform supplies cold Helium gas via a
closed loop circuit, eliminating any need for handling of cryogens. The
patented temperature shielding technology guarantees safe operation and
optimal performance.
Dr. Wolfgang Weber-Fahr, PI of the Translational
Imaging Group at ZI Mannheim, commented: “We are very excited to
work with this new Phased Array MRI CryoProbe technology and will
benefit from the multi-channel array technology that it uses. This will
allow us to push the boundaries of what is possible with MRI and MRS in
rat imaging in the years to come. The close collaboration with Bruker
will allow us to remain state-of-the-art with our MR hardware and
software, and to explore novel preclinical imaging technologies.”
Dr. Wulf Jung, President of Bruker BioSpin’s Preclinical Imaging
Division, added: “We are pleased to take this important next step in MRI
CryoProbe preclinical technology, now extended to rat brain
imaging. Having already proven an exceptional success in neuro and
cardio preclinical imaging of mice applications, we are looking forward
to seeing more benefits from this novel technology, as it brings new
insights into neurodegenerative disease in rat models, beyond what is
possible today.”
Bruker is the pioneer and world leader in the development of
cryogenically-cooled probes for high-resolution NMR, with over 1300
units sold worldwide in the last ten years. That expertise and foresight
has been transferred successfully to the MRI CryoProbe,
and in just the last few years, around 60 of these unique MRI coils have
been successfully installed around the world.
About Bruker Corporation
Bruker Corporation is a leading provider of high performance scientific
instruments and solutions for molecular and materials research, as well
as industrial, diagnostics and applied analysis. For more information,
please visit www.bruker.com.
For more information on Bruker’s preclinical imaging solutions, please
visit www.preclinicalimaging.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140512005171/en/
Source: Bruker Corporation